Skip to main content
Equibles

Bain Capital Life Sciences Investors, LLC

Position in XLO — Xilio Therapeutics, Inc.

CIK 1703031 Boston, MA
Back to XLO Full portfolio

Position in XLO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,361,321
+$776,905 QoQ
Shares Held
664,021
0.0% QoQ
Ownership
11.5%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#1
of 26 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bain Capital Life Sciences Investors, LLC holds $1,318,022,438 across 17 Biotechnology names. XLO ranks #16 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 KLRA
Kailera Therapeutics, Inc.
 22,583,268 $497,509,394
2 NAMS
NewAmsterdam Pharma Co N.V.
 3,906,565 $131,141,499
3 SVRA
Savara Inc
 17,600,621 $108,419,825
4 SLDB
Solid Biosciences Inc.
 9,808,819 $97,990,101
5 PHVS
Pharvaris N.V.
 2,675,509 $92,519,101
6 OLMA
Olema Pharmaceuticals, Inc.
 7,085,249 $88,636,464
7 COAG
Hemab Therapeutics Holdings, Inc.
 1,650,000 $60,604,500
8 CABA
Cabaletta Bio, Inc.
 17,241,445 $53,620,893

All Filings in XLO

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,361,321 664,021
2026-03-31 $5,584,416 664,021
2025-12-31 $4,718,519 7,372,686
2025-09-30 $3,849,826 4,566,817
2025-06-30 $3,105,435 4,566,817
2025-03-31 $3,306,375 4,566,817
2024-12-31 $4,361,310 4,566,817
2024-09-30 $3,598,651 4,566,817
2024-06-30 $3,588,606 3,785,450
2024-03-31 $3,029,846 2,805,413
2023-12-31 $1,542,977 2,805,413
2023-09-30 $5,919,421 2,805,413
2023-06-30 $7,350,182 2,805,413
2023-03-31 $8,893,159 2,805,413
2022-12-31 $7,546,560 2,805,413
2022-09-30 $8,163,751 2,805,413
2022-06-30 $8,191,805 2,805,413
2022-03-31 $19,834,269 2,805,413
2021-12-31 $44,886,607 2,805,413